Halozyme Therapeutics Inc (HALO)

[halofan]

I disagree with you about poor management. I think Helen Torley is doing a very good job of building a strong, profitable company in an important area for patient care. Yes, the stock price movement is very frustrating and has been since the company went public back in 2004. Maybe it’s because so much of the stock is owned by institutions and there are not enough shares being traded on a daily basis which allows for manipulation of the price. I really don’t know, but it’s not due to poor management. If I wanted to complain about Helen, I would say that I wish she could find a way to get more retail investors interested in the company. We know the institutions are interested.